<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Dorsal Root Ganglion Neurons in Chronic Neuropathic Pain</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4023189](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023189)</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Dorsal root ganglia (all spinal levels)</td>
</tr>
<tr>
<td class="label">Morphology</td>
<td>Pseudo-unipolar</td>
</tr>
<tr>
<td class="label">Diameter range</td>
<td>10-100 mum (size correlates with function)</td>
</tr>
<tr>
<td class="label">Myelination</td>
<td>Large: Abeta/Aalpha; Medium: Adelta; Small: Unmyelinated C</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Diameter</td>
</tr>
<tr>
<td class="label">Nociceptors</td>
<td>Small</td>
</tr>
<tr>
<td class="label">Mechanoreceptors</td>
<td>Large</td>
</tr>
<tr>
<td class="label">Thermoreceptors</td>
<td>Small</td>
</tr>
<tr>
<td class="label">Pruriceptors</td>
<td>Small</td>
</tr>
<tr>
<td class="label">Proprioceptors</td>
<td>Large</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Population</td>
</tr>
<tr>
<td class="label">Nav1.7 (SCN9A)</td>
<td>Nociceptors</td>
</tr>
<tr>
<td class="label">Nav1.8 (SCN10A)</td>
<td>Nociceptors</td>
</tr>
<tr>
<td class="label">Nav1.9 (SCN11A)</td>
<td>Nociceptors</td>
</tr>
<tr>
<td class="label">TRPV1</td>
<td>Peptidergic C</td>
</tr>
<tr>
<td class="label">TRPA1</td>
<td>Non-peptidergic</td>
</tr>
<tr>
<td class="label">TRPM8</td>
<td>Cold receptors</td>
</tr>
<tr>
<td class="label">CGRP</td>
<td>Peptidergic</td>
</tr>
<tr>
<td class="label">Substance P</td>
<td>Peptidergic</td>
</tr>
<tr>
<td class="label">IB4 binding</td>
<td>Non-peptidergic</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Molecular Basis</td>
</tr>
<tr>
<td class="label">Na+ channel upregulation</td>
<td>Nav1.3, Nav1.7, Nav1.8 increased</td>
</tr>
<tr>
<td class="label">K+ channel downregulation</td>
<td>KCNQ, KV reduced</td>
</tr>
<tr>
<td class="label">Ca2+ channel changes</td>
<td>Cav3.2 upregulation</td>
</tr>
<tr>
<td class="label">Receptor sensitization</td>
<td>TRPV1, TRPA1 phosphorylation</td>
</tr>
<tr>
<td class="label">Gene expression shifts</td>
<td>ATF3, c-Jun activation</td>
</tr>
<tr>
<td class="label">Gene Class</td>
<td>Changes</td>
</tr>
<tr>
<td class="label">Sodium channels</td>
<td>Nav1.3 up, Nav1.8 down, Nav1.9 down</td>
</tr>
<tr>
<td class="label">Potassium channels</td>
<td>KCNQ2/3 down, KV1.1/1.2 down</td>
</tr>
<tr>
<td class="label">Calcium channels</td>
<td>Cav3.2 up</td>
</tr>
<tr>
<td class="label">Neuropeptides</td>
<td>GAL up, NPY up, SP down, CGRP down</td>
</tr>
<tr>
<td class="label">Neurotrophin receptors</td>
<td>TrkA down, p75 up, Ret up</td>
</tr>
<tr>
<td class="label">Inflammatory mediators</td>
<td>TNF-alpha up, IL-1beta up, IL-6 up</td>
</tr>
<tr>
<td class="label">Transcription factors</td>
<td>ATF3 up, c-Jun up, STAT3 up</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Agent</td>
</tr>
<tr>
<td class="label">Nav1.7</td>
<td>PF-05089771, CNV1014802</td>
</tr>
<tr>
<td class="label">Nav1.8</td>
<td>Suzetrigine (VX-548)</td>
</tr>
<tr>
<td class="label">TRPV1</td>
<td>Capsaicin patch (high-concentration)</td>
</tr>
<tr>
<td class="label">TRPA1</td>
<td>GRC 17536</td>
</tr>
<tr>
<td class="label">Cav2.2</td>
<td>Ziconotide (intrathecal)</td>
</tr>
<tr>
<td class="label">alpha2delta subunits</td>
<td>Gabapentin, pregabalin</td>
</tr>
</table>
Dorsal root ganglion (DRG) neurons are the primary sensory neurons that transmit somatosensory information from peripheral tissues to the spinal cord. In chronic neuropathic pain states, these neurons undergo maladaptive plasticity including sensitization, ectopic firing, and altered gene expression, transforming from faithful sensory transducers into autonomous pain generators. Understanding DRG neuron dysfunction is essential for developing targeted analgesic therapies with improved efficacy and reduced central nervous system side effects.[@woolf2004][@scholz2019]
DRG neuron pathology also contributes to non-motor symptoms in neurodegenerative diseases including Parkinson's disease, where peripheral sensory dysfunction precedes motor symptoms, and in amyotrophic lateral sclerosis, where altered pain processing affects quality of life.
<!-- multi-taxonomy-enrichment -->
DRG neurons are pseudo-unipolar neurons with a single axon that bifurcates into:
DRG neurons are classified by function, size, and molecular markers:
DRG neuron terminals express specialized transducer channels:
The unique pseudo-unipolar morphology allows "through-conduction"—action potentials bypass the soma during normal transmission, traveling directly from peripheral to central terminals. This efficiency is disrupted in neuropathic states.[@krames2015]
Following nerve injury, DRG neurons develop hyperexcitability through:
Injured DRG neurons generate spontaneous action potentials without peripheral input:
Ectopic DRG firing drives spinal cord sensitization through:
Nerve injury triggers a cascade of transcriptional changes in DRG neurons:
Chronic pain induces lasting epigenetic changes:
Following nerve injury, the DRG becomes infiltrated by:
Satellite glial cells (SGCs) envelop each DRG neuron and become activated in neuropathy:
Peripheral sensory dysfunction is an early feature of PD:
Diabetic peripheral neuropathy provides insights into metabolic contributions to neurodegeneration:
Emerging strategies targeting DRG:
The following diagram shows the key molecular relationships involving Dorsal Root Ganglion Neurons in Chronic Neuropathic Pain discovered through SciDEX knowledge graph analysis: